The amphibian pathogen Ambystoma Tigrinum Virus (ATV) has been an important topic of study within the amphibian community since its discovery. ATV threatens many salamander populations across the US, including those in east-central and southeast Arizona. These populations remain at risk since there are no treatments available. In this thesis, a novel method of inactivation is tested to produce a vaccine with the aim of safely eliciting an immune response within the salamander host. This novel form of inactivation has been tested on several human pathogens but has yet to be used on amphibian pathogens. It has the potential to revolutionize our traditional approach to inactivating viruses. After laser treatment, viral plaque assays suggested that inactivated ATV ceased to grow completely, pointing to the possibility of creating a vaccine. Animal challenge trials were conducted with 60 juvenile Ambystoma tigrinum, but surprisingly there was no protective effect from viral inactivation. Further study is needed to clarify why in vitro and in vivo tests of viral inactivation produced contradictory results.